|
MMGT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.90100000080551E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05240000003448E-06 |
| Normal-vs-Stage2 |
7.184200E-04 |
| Normal-vs-Stage3 |
1.49390000370175E-08 |
| Normal-vs-Stage4 |
3.01879999997645E-07 |
| Stage1-vs-Stage2 |
7.226800E-01 |
| Stage1-vs-Stage3 |
2.084800E-01 |
| Stage1-vs-Stage4 |
1.653190E-01 |
| Stage2-vs-Stage3 |
2.168000E-01 |
| Stage2-vs-Stage4 |
1.661040E-01 |
| Stage3-vs-Stage4 |
6.451000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.12260000079334E-08 |
| Normal-vs-AfricanAmerican |
1.983820E-02 |
| Normal-vs-Asian |
1.89911999999293E-05 |
| Caucasian-vs-AfricanAmerican |
1.971170E-01 |
| Caucasian-vs-Asian |
8.296600E-01 |
| AfricanAmerican-vs-Asian |
2.005400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84989999985063E-08 |
| Normal-vs-Female |
3.75619999992693E-07 |
| Male-vs-Female |
1.350770E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.38990000000139E-05 |
| Normal-vs-Age(41-60Yrs) |
1.41139999687567E-08 |
| Normal-vs-Age(61-80Yrs) |
3.67820000013452E-07 |
| Normal-vs-Age(81-100Yrs) |
1.394200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.968250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.885800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.957600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.937200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.967600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.991600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.480400E-02 |
| Classical-VS-Follicular |
7.506300E-02 |
| Classical-VS-Other |
7.266300E-02 |
| Classical-VS-Normal |
2.39960000003592E-06 |
| Tall-VS-Follicular |
4.433200E-01 |
| Tall-VS-Other |
3.436400E-01 |
| Tall-VS-Normal |
4.3766000001888E-07 |
| Follicular-VS-Other |
2.937400E-01 |
| Follicular-VS-Normal |
9.56349999969852E-07 |
| Other-VS-Normal |
5.594500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52779999984531E-07 |
| Normal-vs-N1 |
8.30180002520109E-09 |
| N0-vs-N1 |
2.281800E-02 |
|
|
